The product of PLA2G6 mediates the release of docosahexaenoic acid from brain phospholipids (Green et al., 2008), suggesting that different actions of phospholipases can contribute to the physiopathology of HSP. Here, PLA2G6 is linked to hereditary spastic paraplegia.